OBALON THERAPEUTICS INC Bonus & Incentive Agreements
12 Contracts & Agreements
- ReShape Lifesciences Inc. 2022 Equity Incentive Plan (Filed With SEC on December 20, 2022)
- Retention Bonus Agreement, dated August 2, 2022, by and between the Company and Thomas Stankovich (Filed With SEC on August 2, 2022)
- Form of Stock Option Grant Notice and Stock Option Agreement under ReShape Lifesciences Inc.s Second Amended and Restated 2003 Stock Incentive Plan (Filed With SEC on March 30, 2021)
- Second Amended and Restated 2003 Stock Incentive Plan of ReShape Lifesciences Inc., as amended on May 23, 2018 (Filed With SEC on March 30, 2021)
- Amended and Restated 2016 Equity Incentive Plan and form award agreements thereunder (Filed With SEC on November 6, 2020)
- Form of Restricted Stock Unit Award Agreement (Share and Cash Settlement) pursuant to the 2016 Equity Incentive Plan (Filed With SEC on February 27, 2020)
- Form of Restricted Stock Unit Award pursuant to the 2016 Equity Incentive Plan (Filed With SEC on February 27, 2020)
- Form of Restricted Stock Unit Award pursuant to the 2016 Equity Incentive Plan (Filed With SEC on February 22, 2019)
- First Amendment to 2016 Equity Incentive Plan (Filed With SEC on February 22, 2019)
- NOTICE OF STOCK OPTION GRANT OBALON THERAPEUTICS INC. 2016 EQUITY INCENTIVE PLAN (Filed With SEC on February 23, 2017)
- OBALON THERAPEUTICS, INC. BONUS PLAN (Filed With SEC on September 26, 2016)
- OBALON THERAPEUTICS, INC. 2016 EQUITY INCENTIVE PLAN (Filed With SEC on September 26, 2016)
